The U.S. Supreme Court decided 6-3 to overturn Chevron doctrine on June 28, holding that federal courts may not defer to an agency’s interpretation of an ambiguous statute. In two consolidated cases—Loper Bright Enterprises v. Raimondo and Relentless, Inc. v. Department of Commerce—the court ruled that the Administrative Procedure Act (APA) requires courts to rely…
The U.S. Supreme Court on June 13, 2024, unanimously held in Food and Drug Administration v. Alliance for Hippocratic Medicine that the plaintiffs lacked standing to challenge the Food and Drug Administration’s (FDA) regulatory actions related to approved use conditions of mifepristone—a drug used in medication abortions. The FDA approved the drug mifepristone in 2000…
The United States Supreme Court in April 2024 agreed to hear two cases in the 2024-2025 term concerning a U.S. Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) rule and judicial review of certain decisions made by immigration officials. SCOTUS on April 22 agreed to hear Garland v. VanDerStok—a case challenging the ATF’s authority to…
The United States Supreme Court on January 17, 2024, heard oral argument in Loper Bright Enterprises v. Raimondo and Relentless, Inc. v. Department of Commerce—two consolidated cases challenging an agency’s interpretation of a federal fishery law that could affect future applications of Chevron deference by the federal courts. A coalition of commercial fishermen in Loper…